Literature DB >> 16978533

The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.

Jingsong Wang1, Michael A Maldonado.   

Abstract

Protein degradation through the ubiquitin-proteasome system is the major pathway of non-lysosomal proteolysis of intracellular proteins. It plays important roles in a variety of fundamental cellular processes such as regulation of cell cycle progression, division, development and differentiation, apoptosis, cell trafficking, and modulation of the immune and inflammatory responses. The central element of this system is the covalent linkage of ubiquitin to targeted proteins, which are then recognized by the 26S proteasome, an adenosine triphosphate-dependent, multi-catalytic protease. Damaged, oxidized, or misfolded proteins as well as regulatory proteins that control many critical cellular functions are among the targets of this degradation process. Aberration of this system leads to the dysregulation of cellular homeostasis and the development of multiple diseases. In this review, we described the basic biochemistry and molecular biology of the ubiquitin-proteasome system, and its complex role in the development of inflammatory and autoimmune diseases. In addition, therapies and potential therapeutic targets related to the ubiquitin-proteasome system are discussed as well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978533

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  111 in total

1.  Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to site-specific substrate deamidation.

Authors:  Edward J Dudek; Kirsten J Lampi; Jason A Lampi; Fu Shang; Jonathan King; Yongting Wang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

2.  Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction.

Authors:  Kalavathi Dasuri; Anhthao Nguyen; Le Zhang; Ok Sun Fernandez-Kim; Annadora J Bruce-Keller; Bradford A Blalock; Rafael De Cabo; Jeffrey N Keller
Journal:  Free Radic Res       Date:  2009-01

3.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

4.  A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

Authors:  Simona Perga; Serena Martire; Francesca Montarolo; Nicole D Navone; Andrea Calvo; Giuseppe Fuda; Alberto Marchet; Daniela Leotta; Adriano Chiò; Antonio Bertolotto
Journal:  Neurotox Res       Date:  2017-03-23       Impact factor: 3.911

5.  PYR-41, A Ubiquitin-Activating Enzyme E1 Inhibitor, Attenuates Lung Injury in Sepsis.

Authors:  Shingo Matsuo; Archna Sharma; Ping Wang; Weng-Lang Yang
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

6.  Inhibition of USP14 induces ER stress-mediated autophagy without apoptosis in lung cancer cell line A549.

Authors:  Ali-Asghar Moghadami; Elmira Aboutalebi Vand Beilankouhi; Ashkan Kalantary-Charvadeh; Masoud Hamzavi; Bashir Mosayyebi; Hassan Sedghi; Amir Ghorbani Haghjo; Saeed Nazari Soltan Ahmad
Journal:  Cell Stress Chaperones       Date:  2020-07-06       Impact factor: 3.667

Review 7.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

8.  Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.

Authors:  Nickolay Neznanov; Anton V Gorbachev; Lubov Neznanova; Andrei P Komarov; Katerina V Gurova; Alexander V Gasparian; Amiya K Banerjee; Alexandru Almasan; Robert L Fairchild; Andrei V Gudkov
Journal:  Cell Cycle       Date:  2009-12-25       Impact factor: 4.534

Review 9.  The discovery of novel experimental therapies for inflammatory arthritis.

Authors:  Charles J Malemud
Journal:  Mediators Inflamm       Date:  2010-03-18       Impact factor: 4.711

10.  Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.

Authors:  Lesly De Arras; Rebecca Laws; Sonia M Leach; Kyle Pontis; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  Genetics       Date:  2013-12-20       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.